Zobrazeno 1 - 10
of 12
pro vyhledávání: '"THOMAS NITSOTOLIS"'
Autor:
Thomas Nitsotolis, Konstantinos G. Kyriakoulis, Anastasios Kollias, Alexia Papalexandrou, Helen Kalampoka, Elpida Mastrogianni, Dimitrios Basoulis, Mina Psichogiou
Publikováno v:
Medicina, Vol 60, Iss 2, p 331 (2024)
Background and Objectives: The success of combined antiretroviral therapy (cART) has led to a dramatic improvement in the life expectancy of people living with HIV (PLWH). However, there has been an observed increase in cardiometabolic, bone, renal,
Externí odkaz:
https://doaj.org/article/63acb422fe0743a8b4f7f1073527065f
Autor:
Markela Pagonitsa Zorzou, Maria Chini, Athina Lioni, Georgios Tsekes, Thomas Nitsotolis, Ioannis Tierris, Nicolaos Panagiotou, Dimitra Rontogianni, Nicolaos Harhalakis, Marios Lazanas
Publikováno v:
Hematology Reports, Vol 8, Iss 4 (2016)
Although the connection of [secondary hemophagocytic syndrome (sHS)] with HIV has been well documented, optimal treatment regimen is not well established. This is due not only to the rarity of the syndrome, but also to the heterogeneity of the involv
Externí odkaz:
https://doaj.org/article/ddf170e15f74484b9a618de1226cf04c
Autor:
Panteleimon Tsiamalos, Iro Rapti, Androniki Papapostolou, Thomas Nitsotolis, Chrysanthi Sidiropoulou, Haralampos Milionis, Konstantinos N. Syrigos, Antonios Tsakiris, Konstantina Katrini, Eleftherios Klouras, Evangelos J. Giamarellos-Bourboulis, Emmanouil Vrentzos, George Chrysos, Georgios Tsibris, Periklis Panagopoulos, Dimitra-Melia Myrodia, Vagia Zarkada, Theologia Gkavogianni, Garyphallia Poulakou, Evangelos Michelakis, Konstantinos Tsiakos, Maria Georgiopoulou, Christina Damoulari, Vasileios Petrakis, Maria Kosmidou, Sofia Artemi, Areti Gravvani, Panagiotis Koufargyris, Pantazis-Michael Voutsinas, Anastasios Ioannidis, Athanassios Karageorgos
Publikováno v:
Infectious Diseases and Therapy
Introduction The anti-inflammatory effect of macrolides prompted the study of oral clarithromycin in moderate COVID-19. Methods An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October
Autor:
Konstantinos N. Syrigos, Garyphallia Poulakou, Ioannis G. Kyriakoulis, Konstantinos G. Kyriakoulis, Anastasios Kollias, Thomas Nitsotolis, George S. Stergiou
Publikováno v:
Atherosclerosis. 330:114-121
Background and aims Statin therapy is administered to patients with high cardiovascular risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID-19). Statins exhibit not only cardioprotective but also immunomodulator
Autor:
Konstantinos G. Kyriakoulis, Konstantinos N. Syrigos, Thomas Nitsotolis, Garyphallia Poulakou
Publikováno v:
Expert Review of Respiratory Medicine. 15:967-971
Introduction The art of clinical examination has been the cornerstone of medical practices since ancient years. Recent technological achievements and their overuse have led falsely to underestimation of their significance, which has been further ques
Autor:
Evdoxia Kyriazopoulou, Nikolaos Alexiou, Styliani Lagou, Lydia Liaskou-Antoniou, Thomas Nitsotolis, Miltiades Kyprianou, Elina Drakou, Andronikos Spyrou, George Adamis, Virginia Kolonia, Anna Makina, Garyfallia Poulakou, Styliani Symbardi, Nikolaos Melachroinopoulos, Theologia Gkavogianni, Konstantinos Marousis, Malvina Lada, Marina Koupetori, Zoi Alexiou, Efrosyni Roulia, Antonia Panagaki, Evangelos J. Giamarellos-Bourboulis, Georgios Chrysos, Vasileios Apostolopoulos, Anastasia Antoniadou, Dimitra Petrou, Ioannis Anagnostopoulos
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: Although early antimicrobial discontinuation guided by procalcitonin (PCT) has shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in long-term sepsis sequelae remain unclear. Objectives: To investiga
Publikováno v:
Expert Review of Anti-infective Therapy. 19:825-844
Introduction: Ventilator-associated pneumonia (VAP) is a common and potentially fatal complication of mechanical ventilation that is often caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB). Despite the repurposing of older treatments a
Autor:
EVANGELOS DIMAKAKOS, ANASTASIOS KOLLIAS, VASILIKI RAPTI, KONSTANTINOS G. KYRIAKOULIS, IOANNIS P. TRONTZAS, MAHMOUD M. ABDELRASOUL, STAVROULA ZANELLI, KONSTANTINOS LEONTIS, KATERINA ARGYRAKI, KATERINA DIMAKOU, GEORGIOS TSOUKALAS, KALOMIRA ATHANASIOU, THOMAS NITSOTOLIS, KONSTANTINOS N. SYRIGOS, GARYPHALLIA POULAKOU
Publikováno v:
In Vivo
Background/Aim: This study analyzed the characteristics of patients with COVID-19 with major events during the first days of hospitalization. Patients and Methods: This is a retrospective analysis of prospectively collected data from consecutive pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808dcc0327b77b6cff933a6844c66ad3
https://europepmc.org/articles/PMC8765153/
https://europepmc.org/articles/PMC8765153/
Autor:
Anastasios, Kollias, Konstantinos G, Kyriakoulis, Vasiliki, Rapti, Ioannis P, Trontzas, Thomas, Nitsotolis, Konstantinos, Syrigos, Garyphallia, Poulakou, Qiancheng, Xu
Publikováno v:
In Vivo
Background/Aim: Evidence suggests a beneficial effect of prone positioning (PP) in COVID-19. Materials and Methods: Meta-analysis of individual (7 investigators’ groups) and aggregate data (PubMed/EMBASE) regarding the impact of PP on the ratio of
Autor:
Panteleimon Tsiamalos, Maria Kosmidou, Areti Gravvani, Evangelos Michelakis, Panagiotis Koufargyris, Pantazis Voutsinas, Vasileios Petrakis, George Chrysos, Periklis Panagopoulos, Dimitra-Melia Myrodia, Theologia Gkavogianni, Sofia Artemi, Emmanouil Vrentzos, Androniki Papapostolou, Evangelos J. Giamarellos-Bourboulis, Thomas Nitsotolis, Anastasios Ioannidis, Konstantinos N. Syrigos, Konstantinos Tsiakos, Maria Georgiopoulou, Iro Rapti, Garyphallia Poulakou, Athanassios Karageorgos, Vagia Zarkada, Chrysanthi Sidiropoulou, Christina Damoulari, Gerorgios Tsibris, Haralampos Milionis, Antonios Tsakiris, Konstantina Katrini, Eleftherios Klouras
BackgroundTo study the efficacy of oral clarithromycin in moderate COVID-19.MethodsAn open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October 2020. The primary endpoint was defined at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::805dff4849ad70e05cdee10d37ad8adc
https://doi.org/10.1101/2020.12.22.20248753
https://doi.org/10.1101/2020.12.22.20248753